PEMF in the Treatment of Fresh Distal Radius Fractures
Distal Radius Fracture
About this trial
This is an interventional treatment trial for Distal Radius Fracture
Eligibility Criteria
Inclusion Criteria:
- Subjects with closed unilateral dorsally angulated fracture of the distal radius (Colles') visible by x-ray.
- Subjects treated conservatively by immobilization ± closed reduction
- Age >18 years
- Subjects able to adhere to the visit schedule and protocol requirements and be available to complete the study.
Exclusion Criteria:
- Subjects with intra articular fracture or extra-articular fracture that meets the criteria for operative fracture fixation.
- Subjects with pins or plates in the wrist
- Sustained previous fractures or bone surgery in the currently fractured distal forearm
- Synovial pseudarthrosis
- Subjects with multiple trauma (several fractures at once)
- Subjects suffering from joint diseases that affect the function of the wrist and/or hand of the injured arm.
- Pregnancy
- Women who are breast-feeding.
- Women of childbearing potential and not using a medically accepted form of contraception when sexually active.
- presence of a life supporting implanted electronical device
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
Standard treatment + Active FHP
Standard treatment + Sham FHP
The PEMF device - FHP (supplied by commercial support) will be placed under the cast in the ER after diagnosing the fracture and will be applied for 24 hours a day continuously for 30-40 days.
Half of the PEMF devices will be not activated at random before the application to the patients. Two types of activators will be provided by the company: active and sham. Sham activated devices will give outward signs of normal function but will not generate a signal. The investigators will be unaware of the device's functionality. The patients will not be able to determine whether the device is working or not. At study completion, device serial numbers will be used to determine which patients received a working device. The company supplying the PEMF-devices will have no knowledge of patient outcome.